Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGlaukos Corporation
About this trial
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of Open-angle glaucoma
18 years of age or older
Disqualifiers
Subject who is breast-feeding or pregnant
Trial population
Adult subjects with OAG or OHT
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Travoprost
Combination productTravoprost intracameral implant, 75mcg administered using the sterile, single-dose updated inserter (Model G2-TRIO)
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: Model G2-TRIO1 intervention
Trial outcomes
Primary outcomes
1
Successful implantation
Proportion of subjects for which Investigator was able to successfully follow the Instructions For Use/Prescribing Information and correctly administer the model G2-TRIO travoprost intracameral implant 75mcg with the updated inserter
Time frame
1 daySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov